Axsome Therapeutics’ (AXSM) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright restated their buy rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research report released on Tuesday, Marketbeat Ratings reports. HC Wainwright currently has a $180.00 price target on the stock. A number of other equities research analysts have also recently commented on AXSM. Cantor Fitzgerald restated an overweight rating […]
More Stories
Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Sold by Baird Financial Group Inc.
Baird Financial Group Inc. lowered its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 90.8% during the fourth...
Captrust Financial Advisors Has $1.05 Million Position in Gates Industrial Corp PLC (NYSE:GTES)
Captrust Financial Advisors increased its position in Gates Industrial Corp PLC (NYSE:GTES – Free Report) by 11.7% during the fourth...
Northern Trust Corp Raises Stake in Under Armour, Inc. (NYSE:UAA)
Northern Trust Corp increased its stake in Under Armour, Inc. (NYSE:UAA – Free Report) by 18.9% during the 4th quarter,...
Mercer Global Advisors Inc. ADV Boosts Stock Position in Plug Power Inc. (NASDAQ:PLUG)
Mercer Global Advisors Inc. ADV lifted its position in shares of Plug Power Inc. (NASDAQ:PLUG – Free Report) by 75.1%...
BNP Paribas Financial Markets Acquires New Stake in AST SpaceMobile, Inc. (NASDAQ:ASTS)
BNP Paribas Financial Markets acquired a new stake in shares of AST SpaceMobile, Inc. (NASDAQ:ASTS – Free Report) in the...
New Jersey Train Engineers Go On Strike, Halting Service in New York City Area
By Oliver Mantyk NEW YORK CITY—New Jersey Transit train engineers went on strike on May 16, halting service to 350,000...